MBA
LAW
LANGUAGES

DEPOMED INC. DEPO (NASDAQ)

$ 1.37

11/18/2008 20:09

Sponsored by

Change: unch (unch%)
Volume: 242,865

Avg. Volume:	192063
P/E Ratio:	12
EPS (Annual):	0.41
Profit Margin:
Dividend & Yield(Annual):	0%
Shares Outstanding:	48,120
Institutional Shareholders:	49.26%

Last:	1.37
Change:	unch (unch%)
Prev. Close:	1.37
Open:	1.60
Day's Range:	1.36 - 1.70
52wk Range:	1.36 - 4.52
Market Value:	76,030
Beta:	1.61

12-month EPS Change:	0.00%
Total Return Last 12 Months:	-47.10%
Total Return Last 3 Years:	-148.65%
Total Return Last 5 Years:	-80.48%
5-Year Revenue Growth Rate:	0.00%
5-Year Dividend Growth Rate:	0.00%
5-Year EPS Growth Rate:	0.00%

Headlines on DEPO

Alert me

Santarus to promote Depomed diabetes drug

(SAN DIEGO)Santarus Inc. said Tuesday it agreed to promote Depomed Inc.'s diabetes drug Glumetza in the U.S., and will pay Depomed up to $28 million in return for a portion of sales from the ...READ MORE

Jul 22, 2008 11:27AM

Keywords: SNTS, DEPO, BVF, KG

Depomed gets $15 million loan to help develop drug

(MENLO PARK, Calif.)Depomed Inc. said Monday it negotiated a $15 million senior secured loan with Oxford Finance Corp. and GE Healthcare Financial Services that will be funded in three parts through S...READ MORE

Jun 30, 2008 2:42PM

Keywords: DEPO

Russell 2000 adds 53 health care companies

(NEW YORK)More than 50 companies in the health care sector were added to the Russell 2000 in this year's reconstitution of the small stock index, while 30 companies in the sector were re...READ MORE

Jun 30, 2008 2:16PM